Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(2S,3R,4S)-CCG is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

117857-95-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 117857-95-1 Structure
  • Basic information

    1. Product Name: (2S,3R,4S)-CCG
    2. Synonyms: (2S,3S,4R)-CCG;(2S,3R,4S)-ALPHA-(CARBOXYCYCLOPROPYL)GLYCINE;(2S,3R,4S)-CCG;(2S,1'R,2'S)-2-(CARBOXYCYCLOPROPYL)GLYCINE;(2S,1'S,2'R)-2-(CARBOXYCYCLOPROPYL)GLYCINE;L-CCG-III;L-CCG-IV;(2S,1'R,2')-2-(2-carboxycyclopropyl)*glycine
    3. CAS NO:117857-95-1
    4. Molecular Formula: C6H9NO4
    5. Molecular Weight: 159.14
    6. EINECS: N/A
    7. Product Categories: Glutamate receptor
    8. Mol File: 117857-95-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: off-white/solid
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: Store at RT
    8. Solubility: H2O: soluble
    9. CAS DataBase Reference: (2S,3R,4S)-CCG(CAS DataBase Reference)
    10. NIST Chemistry Reference: (2S,3R,4S)-CCG(117857-95-1)
    11. EPA Substance Registry System: (2S,3R,4S)-CCG(117857-95-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 117857-95-1(Hazardous Substances Data)

117857-95-1 Usage

Uses

L-CCG-IV is a potent small molecule agonist at the NMDA receptor.

Biological Activity

Potent and competitive inhibitor of both glial and neuronal uptake of glutamate, aspartate and cysteate.

Biochem/physiol Actions

Potent NMDA receptor agonist.

Check Digit Verification of cas no

The CAS Registry Mumber 117857-95-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,8,5 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 117857-95:
(8*1)+(7*1)+(6*7)+(5*8)+(4*5)+(3*7)+(2*9)+(1*5)=161
161 % 10 = 1
So 117857-95-1 is a valid CAS Registry Number.

117857-95-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (C195)  (2S,3R,4S)-α-(Carboxycyclopropyl)glycine  solid

  • 117857-95-1

  • C195-1MG

  • 2,734.29CNY

  • Detail

117857-95-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (1S,2R)-2-[(S)-amino(carboxy)methyl]cyclopropane-1-carboxylic acid

1.2 Other means of identification

Product number -
Other names L-CCG-IV

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:117857-95-1 SDS

117857-95-1Relevant articles and documents

Synthesis and reactions of a novel 3,4-didehydropyroglutamate derivative

Oba, Makoto,Nishiyama, Naohiro,Nishiyama, Kozaburo

, p. 776 - 777 (2003)

Some reactions such as catalytic hydrogenation, Diels-Alder reaction, cyclopropanation, dihydroxylation, and Michael addition of a novel 3,4-didehydropyroglutamate derivative, in which the carboxylic group is protected as an ABO ester, are examined and found to take place in a stereospecific manner giving 3- and/or 4-substituted pyroglutamate derivatives without loss of enantiomeric purity at the α-position.

Synthesis of cyclopropanes via organoiron methodology: Stereoselective preparation of cis-2-(2′-carboxycyclopropyl)glycine

Wallock, Nathaniel J,Donaldson, William A

, p. 4541 - 4543 (2002)

A stereoselective route to cis-2-(2′-carboxycyclopropyl)glycine has been developed. exo-Nucleophilic addition to the (bicyclo[5.1.0]octadienyl)iron(1+) cation establishes the relative stereochemistry at the cyclopropane ring and the α-stereocenter. Subsequent removal of the metal and cleavage of the cyclic diene gave the protected target 10, which upon hydrolysis gave 1.

Novel stereocontrolled approach to conformationally constrained analogues of L-glutamic acid and L-proline via stereoselective cyclopropanation of 3,4-didehydro-L-pyroglutamic ABO ester

Oba, Makoto,Nishiyama, Naohiro,Nishiyama, Kozaburo

, p. 8456 - 8464 (2007/10/03)

A new stereocontrolled approach to l-(carboxycyclopropyl)glycines (l-CCGs) and 3,4-methano-l-prolines, conformationally constrained analogues of l-glutamic acid and l-proline, respectively, was developed using a 3,4-didehydro-l- pyroglutamate derivative as a common chiral template. The unsaturated l-pyroglutamate derivative employed in this work is a novel chiral synthon in which the carboxyl functionality is protected as a 2,7,8-trioxabicyclo[3.2.1] octyl group (ABO ester). Stereospecific cyclopropanation of the olefin using diazomethane followed by appropriate functional group interconversion gave l-CCG-III and trans-3,4-methano-l-proline with complete stereocontrol. Synthesis of other diastereomers of l-CCG and cis-3,4-methano-l-proline was accomplished by alteration of the 3,4-methanoglutamic acid framework via carboxycyclopropanation of the olefin with sulfur ylide and subsequent Barton decarboxylation reaction of the original γ-carboxyl group included in the pyroglutamate skeleton.

Reactivity of (Bicyclo[5.1.0]octadienyl)iron(1+) Cations: Application to the Synthesis of cis-2-(2′-Carboxycyclopropyl)glycines

Wallock, Nathaniel J.,Donaldson, William A.

, p. 2997 - 3007 (2007/10/03)

The addition of carbon and heteroatom nucleophiles to (bicyclo[5.1.0]octadienyl)Fe(CO)2L+ cations 5 or 8 (L = CO, PPh3) generally proceeds via attack at the dienyl terminus on the face of the ligand opposite to iron to generate 6-substituted (bicyclo[5.1.0]octa-2,4-diene)iron complexes (11 or 13). In certain cases, these products are unstable with respect to elimination of a proton and the nucleophilic substituent to afford (cyclooctatetraene)Fe(CO)2L (4 or 7). Decomplexation of 13f, arising from addition of phthalimide to 8, gave N-(bicyclo[5.1.0]octa-3,5-dien-2-yl)phthalimide (19). Oxidative cleavage of 19 (RuCl3/NaIO4) followed by esterification gave the cyclopropane diester 22, which upon hydrolysis gave cis-2-(2′ -carboxycyclopropyl)glycine (CCG-III, 18) (eight steps from 4, 43% overall yield). This methodology was also utilized for preparation of stereospecifically deuterated CCG-III (d-18) and optically enriched (-)-18. Deprotonation of 22 resulted in cyclopropane ring opening to afford the benzoindolizidine (23).

Novel enantioselective synthesis of trans-α-(2-carboxycyclo-prop-1- yl)glycines: Conformationally constrained L-glutamate analogues

Demir, Ayhan S.,Tanyeli, Cihangir,Cagir, Ali,Nawaz Tahir,Ulku, Dincer

, p. 1035 - 1042 (2007/10/03)

D- and L-α-(2-carboxycycloprop-1-yl)glycines were synthesized from trans-1,3-di(2-furyl)propenone. Conversion of the double bond to a cyclopropane is followed by the formation of an oxime ether. Enantioselective reduction of the oxime ether, separation of diastereomers and oxidation of the furane rings gave enantiomerically pure D- and L-CCG I and CCG II. The structure of oxime 7b was determined by X-ray crystal structure analysis. The key step is the oxazaborolidine catalyzed enantioselective conversion of oxime ethers to amines.

Facile synthesis of (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine an isotype-selective agonist of metabotropic glutamate receptors

Ma, Dawei,Ma, Zhaochun

, p. 7599 - 7602 (2007/10/03)

(2S,1'S,2'S)-2-(Carboxycyclopropyl)glycine (L-CCG-I) was synthesized in 12 steps and 14% overall yield by using Sharpless's asymmetric dihydroxylation reaction and stereochemically controlled cyclopropanation as key steps.

Study of the reactivity profile of glycine Schiff's bases with dipolarophiles: Application towards a concise synthesis of CCG-II

Chavan, Subhash. P.,Venkatraman,Sharma, Anil. K.,Chittiboyina, Amar Gopal

, p. 2857 - 2858 (2007/10/03)

The reactivity profile of glycine Schiff's bases with crotonate and bromocrotonate has been shown to take a different course depending on the choice substituent on the imine. Application of the above study for the mild and concise synthesis of CCG-II has been achieved.

Synthesis of Four Diastereomeric L-2-(Carboxycyclopropyl)glycines. Conformationally Constrained L-Glutamate Analogues

Shimamoto, Keiko,Ishida, Michiko,Shinozaki, Haruhikio,Ohfune, Yasufumi

, p. 4167 - 4176 (2007/10/02)

To determine what conformations of L-glutamate (L-Glu) activate that compound's different receptors in the mammalian central nervous system, four diastereochemically L-2-(carboxycyclopropyl)glycines, 1-4, which are conformationally constrained analogues o

D-3,4-'cyclopropylglutamate' isomers as nmda receptor ligands: Synthesis and enantioselective activity

Pellicciari, Roberto,Natalini, Benedetto,Marinozzi, Maura,Monahan, Joseph B.,Snyder, James P.

, p. 139 - 142 (2007/10/02)

Dirhodium(II) tetraacetate catalyzed decomposition of ethyl diazoacetate in the presence of D-Cbz-vinylglycine methyl ester (11) afforded a mixture of the cyclopropyl esters D-CGA A-D (13) from which the corresponding 2R-acids 7-10 were obtained and their absolute configurations assigned. The (2R,3S,4R) α-(carboxycyclopropyl)glycine (D-CGA C, 9 resulted to be the most potent and selective among the NMDA receptor ligands yet reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 117857-95-1